Prednisone reduction for metastatic castration-resistant prostate cancer with recurrent pulmonary tuberculosis: Case report

INTRODUCTION: Prednisone (10 mg/d) is often used in combination with docetaxel or abiraterone in the treatment of advanced prostate cancer. LATITUDE studies have confirmed that the combination of abiraterone and prednisone (5 mg/d) can be used for the treatment of newly diagnosed high-risk metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaojuan, Shi, Zhenguo, Gao, Shegan, Wang, Xiaohong, Wang, Pei, Kang, Chongzhao, Zhao, Fangzong, Hou, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052077/
https://www.ncbi.nlm.nih.gov/pubmed/33847689
http://dx.doi.org/10.1097/MD.0000000000025584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052077/
https://www.ncbi.nlm.nih.gov/pubmed/33847689
http://dx.doi.org/10.1097/MD.0000000000025584

Ejemplares similares